<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">85</article-id>
      <article-id pub-id-type="doi">10.31348/2018/1/6-3-2018</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Congentinal Central Toxoplasma Chorioretinitis - Case Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Maršolková</surname>
            <given-names>Kristýna</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Timkovič</surname>
            <given-names>Juraj</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0767-0552</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lesková</surname>
            <given-names>Veronika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Němčanský</surname>
            <given-names>Jan</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1979-6419</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wiedermannová</surname>
            <given-names>Hana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>15</day>
        <month>10</month>
        <year>2018</year>
      </pub-date>
      <issue>3</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>Congenital toxoplasmosis is a globally spread infectious disease caused by transplacental transmission of an intracellular parasitic protozoan Toxoplasma gondii. The infection can cause serious multi-organ complications, and in the case of vertical transmission, can lead up to fetal death – depending on the stage of pregnancy at the time of infection and the overall condition of the mother’s immune system. Chorioretinitis, hydrocephalus and intracranial calcifications are a typical triad of symptoms associated with the disease. Toxoplasmic chorioretinitis in particular is the most common ocular manifestation. If the central retina is affected, it can cause a severe impairment of central visual acuity or lead up to blindness in the child. Prenatal screening of this disease is presently voluntary in the Czech Republic. This article reports on a case study of a toxoplasmic chorioretinitis in a newborn child observed from the active stage and the development of the affected retina over time. Further is also reported on the diagnostics and the treatment of multi-organ complications which occurred in this patient. Ophthalmologic examination was performed after diagnosis of hydrocephalus, which revealed severe changes of retina. Hydrocephalus was then properly treated. An overview of the diagnostic and therapeutic methods and the screening options available in the Czech Republic compare with other countries is also presented in the report.</p>
      </abstract>
      <kwd-group>
        <kwd>congenital toxoplasmosis</kwd>
        <kwd>chorioretinitis</kwd>
        <kwd>multi-organ complications</kwd>
        <kwd>screening</kwd>
        <kwd>hydrocephalus</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R7836">
        <mixed-citation>Bischoff, A.R., Friedrich, L., Cattan, J.M. et al.: Incidence of Symptomatic Congenital Toxoplasmosis During Ten Years in a Brazillian Hospital. Pediatr Infect Dis J, 35; 2016: 1313-1316.</mixed-citation>
      </ref>
      <ref id="R7837">
        <mixed-citation>Boyer, K., Hill, D., Mui, E. et al.: Unrecognized Ingestion of Toxoplasma gondii Oocysts Leads to Congenital Toxoplasmosis and Causes Epidemics in North America. CID, 53; 2011: 1081-1089.</mixed-citation>
      </ref>
      <ref id="R7838">
        <mixed-citation>Faucher, B., Garcia-Meric, P., Franck, J., et al.: Long-term ocular outcome in congenital toxoplasmosis: A prospective kohort of treated children. J Infect, 64; 2012:104-109.</mixed-citation>
      </ref>
      <ref id="R7839">
        <mixed-citation>Geleneky, M., Prášil, P., Kodym, P.: Doporučený postup pro diagnostiku a léčbu toxoplasmózy [online]. Schváleno výborem Společnosti infekčního lékařství ČLS JEP v červnu 2017, datum vydání 7. listopadu 2017. Dostupné na WWW: &lt; https://www.infekce.cz/DoporToxo17. htm &gt;.</mixed-citation>
      </ref>
      <ref id="R7840">
        <mixed-citation>Guha, R., Miley, L., Aspiri M. et al.: Con - genital Toxoplasmosis. Pediatr Neurol, 70; 2017: 81-82.</mixed-citation>
      </ref>
      <ref id="R7841">
        <mixed-citation>Handl, V.K., Klingelhöfer, D., Schlöffel, N. et al.: Kongenitale Toxoplasmose und Toxoplasma gondii. Zbl Arbeitsmed, 66; 2016: 239-248.</mixed-citation>
      </ref>
      <ref id="R7842">
        <mixed-citation>In Pepose J.S., Holland, G.H., Wilhalmus, K.R.: Ocular Infection Immunity. Mosby, St.Lois, 1996, p. 1183-1224.8.</mixed-citation>
      </ref>
      <ref id="R7843">
        <mixed-citation>Janků, J.: Pathogenesa a patologická anatomie tak nazvaného vrozeného kolobomu žluté skvrny v oku normálně velikém a mikrophtalmickém s nálezem parasitů v sítnici.Cas Lek Ces, 62; 1923: 1021-1027.</mixed-citation>
      </ref>
      <ref id="R7844">
        <mixed-citation>Janku J.: Die patogenese ung patho - logishe Anatomie des sogenannten angeborenen Koloboms des gelben Fleckes im normal grossen sowie im mikrophthalmishen Auge mit Parasitenbefund in der Netzhaut. Cls Parasit, 6; 1959: 9-16.</mixed-citation>
      </ref>
      <ref id="R7845">
        <mixed-citation>Kartasasmita, A., Muntur, W.P., Enus, S. et al.: Rapid resolution of toxoplasma chorioretinitis treatment using quadruple therapy. Clin Ophthalmol, 11; 2017: 2133-2137.</mixed-citation>
      </ref>
      <ref id="R7846">
        <mixed-citation>Korol, A.R., Zborovska, O., Kustryn, T. et al.: Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol, 11; 2017: 1315-1320.</mixed-citation>
      </ref>
      <ref id="R7847">
        <mixed-citation>Melamed, J., Eckert, G.U., Spadoni, V.S. et al.: Ocular manifestations of congenital toxoplasmosis. Eye, 24; 2010: 528-534.</mixed-citation>
      </ref>
      <ref id="R7848">
        <mixed-citation>Modrzejewska, M., Patalan, J., Kulik, U. et al.: Ocular manifestation of congenital toxoplasmosis, clinical implication – case report. Ginekol Pol, 87; 2016:226- 230.</mixed-citation>
      </ref>
      <ref id="R7849">
        <mixed-citation>Paulová M., Vignerová J., Riedlová J.: Individuální hodnocení růstu pomocí růstových grafů se zaměřením na děti do 2 let. Neonatologické listy 15; 2009: 3-9.</mixed-citation>
      </ref>
      <ref id="R7850">
        <mixed-citation>Prusa, A-R., Kasper, D.C., Sawers, L. et al.: Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving. PloS Negl Trop Dis. 2017, č. 11 [cit. 2017-04-21]. Dostupný na WWW: &lt; http://doi.org/10.1371/journal.pntd.0005648 &gt;.<pub-id pub-id-type="doi">10.1371/journal.pntd.0005648</pub-id></mixed-citation>
      </ref>
      <ref id="R7851">
        <mixed-citation>Rishi P.,Venkataraman A., Rishi E.: Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol. 2011;59(1):62-64.</mixed-citation>
      </ref>
      <ref id="R7852">
        <mixed-citation>Robert-Gangneux, F., Dard M.-L.: Epi - demiology of and Diagnostic Strategies for Toxoplasmosis. Clin Microbiol Rev. 2012 Apr; 25(2): 264–296.</mixed-citation>
      </ref>
      <ref id="R7853">
        <mixed-citation>Rothova, A., Meenken, C., Buitenhuis, H.J. et al.: Therapy for Ocular Toxoplasmosis. Am J Ophthalmol, 115; 1993:517-523.</mixed-citation>
      </ref>
      <ref id="R7854">
        <mixed-citation>Sahinoglu-Keskek, N., Unal F., Cevher, S. et al.: Cause of visual impairment in patiens with ocular toxoplasmosis. J Infect dev Ctries, 11; 2017:192-195.</mixed-citation>
      </ref>
      <ref id="R7855">
        <mixed-citation>Shah NJ, Shah UN.: Intravitreal ranibi - zumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Indian J Ophthalmol. 2011;59(4):318-319.</mixed-citation>
      </ref>
      <ref id="R7856">
        <mixed-citation>Smit, S.A., Padalko, E., Acker, J.V. et al.: Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis. CID, 20; 2017: 1-8.</mixed-citation>
      </ref>
      <ref id="R7857">
        <mixed-citation>Souza, C.E., Nascimento, H., Lima, A. et al.: Intravitreal Injection of Sulfametoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis. Ocul Immunol Inflamm, 00; 2017:1-4.</mixed-citation>
      </ref>
      <ref id="R7858">
        <mixed-citation>Surveillance Atlas of Infectious Diseases. Dataset provided by ECDC based on data - provided by WHO and Ministries of Health from the affected countries. Dostupné na WWW: &lt; http://atlas. ecdc.europa.eu/public/index.aspx &gt;.</mixed-citation>
      </ref>
      <ref id="R7859">
        <mixed-citation>Wallon, M., Garweg, J.G., Abrahamowicz, M. et al.: Ophthalmic Outcomes of Congenital Toxoplasmosis Followed Until Adolescence. Pediatrics, 133; 2014: e601-e608. 25.. Wallon, M., Peyron, F.: Congenital Toxoplasmosis: A Plea for a Neglected Disease. Pathogens, 7; 2018: 25.</mixed-citation>
      </ref>
      <ref id="R7860">
        <mixed-citation>Zamora, Y.F., Arantes, T., Reis, F.A. et al.: Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone. Arq Bras Oftalmol, 78; 2015: 216-219.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
